MARINO MERLO, Francesca
 Distribuzione geografica
Continente #
EU - Europa 6.064
NA - Nord America 6.011
AS - Asia 2.706
SA - Sud America 926
Continente sconosciuto - Info sul continente non disponibili 163
AF - Africa 82
OC - Oceania 7
Totale 15.959
Nazione #
US - Stati Uniti d'America 5.885
RU - Federazione Russa 3.064
SG - Singapore 1.111
CN - Cina 793
BR - Brasile 783
IE - Irlanda 684
SE - Svezia 593
IT - Italia 541
HK - Hong Kong 284
DE - Germania 241
FR - Francia 232
UA - Ucraina 188
VN - Vietnam 165
FI - Finlandia 145
PL - Polonia 133
GB - Regno Unito 105
IN - India 86
CA - Canada 58
AR - Argentina 43
ID - Indonesia 34
BD - Bangladesh 32
EC - Ecuador 30
MX - Messico 26
IQ - Iraq 25
CZ - Repubblica Ceca 23
MA - Marocco 22
TR - Turchia 22
ZA - Sudafrica 22
CO - Colombia 21
JP - Giappone 21
UZ - Uzbekistan 20
AT - Austria 19
BE - Belgio 18
NL - Olanda 18
PK - Pakistan 16
VE - Venezuela 15
AE - Emirati Arabi Uniti 11
ES - Italia 10
UY - Uruguay 10
AZ - Azerbaigian 9
IR - Iran 8
KE - Kenya 8
LT - Lituania 8
MY - Malesia 8
TN - Tunisia 8
CL - Cile 7
HN - Honduras 7
IL - Israele 7
JO - Giordania 7
PY - Paraguay 7
CR - Costa Rica 6
PA - Panama 6
PE - Perù 6
TT - Trinidad e Tobago 6
CI - Costa d'Avorio 5
EG - Egitto 5
KZ - Kazakistan 5
PH - Filippine 5
RS - Serbia 5
BY - Bielorussia 4
CH - Svizzera 4
CW - ???statistics.table.value.countryCode.CW??? 4
KR - Corea 4
LB - Libano 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
OM - Oman 4
SA - Arabia Saudita 4
AL - Albania 3
AU - Australia 3
BH - Bahrain 3
BO - Bolivia 3
DZ - Algeria 3
EU - Europa 3
GP - Guadalupe 3
JM - Giamaica 3
NP - Nepal 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
IM - Isola di Man 2
NG - Nigeria 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SV - El Salvador 2
TW - Taiwan 2
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
Totale 15.790
Città #
Ashburn 921
Moscow 877
Dallas 691
Dublin 684
Singapore 603
Chandler 519
San Jose 418
Nyköping 414
Jacksonville 376
Beijing 308
Hong Kong 284
Council Bluffs 208
The Dalles 161
Los Angeles 150
Warsaw 128
Messina 117
Lauterbourg 106
Princeton 106
Medford 97
Cambridge 96
Ann Arbor 91
Munich 85
Des Moines 79
Dearborn 74
New York 69
Rome 63
Boardman 60
São Paulo 59
Buffalo 53
Ho Chi Minh City 38
Turku 38
Wilmington 37
Jinan 36
Orem 36
Tianjin 36
San Mateo 35
Santa Clara 34
Hanoi 32
Redondo Beach 31
Rio de Janeiro 31
Woodbridge 30
Guangzhou 28
Brooklyn 24
Shenyang 23
Nanjing 21
Tokyo 21
Houston 20
Montreal 20
Tashkent 20
Milan 19
Phoenix 19
Atlanta 18
Brasília 18
Brussels 18
Frankfurt am Main 18
Pune 18
Stockholm 18
Chennai 17
Jakarta 17
Chicago 16
Columbus 16
Dong Ket 16
Helsinki 16
London 15
Quito 15
Washington 15
Catania 14
Ningbo 14
Olomouc 14
Seattle 14
Shanghai 14
Vienna 14
Amsterdam 13
Francofonte 13
San Francisco 13
Zhengzhou 13
Boston 12
Hangzhou 12
Johannesburg 12
Mumbai 12
Augusta 11
Belo Horizonte 11
Charlotte 11
Denver 11
Hyderabad 11
Nanchang 11
Poplar 11
Baghdad 10
Turin 10
Ankara 9
Baku 9
Bogotá 9
Palermo 9
Ribeirão Preto 9
Düsseldorf 8
Falls Church 8
Fortaleza 8
Haikou 8
Joinville 8
Manaus 8
Totale 9.151
Nome #
Studio di nuove formulazioni di rivestimenti protettivi per imbarcazioni con proprietà antivegetative 255
Amphiphilic cyclodextrins as capping agents for gold colloids: A spectroscopic investigation with perspectives in photothermal therapy 235
Molecular surveillance of healthcare-associated Candida infections in a rehabilitation center for patients with severe acquired brain injuries 234
Effetto della presenza di nanotubi di carbonio sulle proprietà meccaniche, fisiche e biologiche di nanocompositi a base di resina poliestere 227
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 218
A novel, rapid assay for evaluating the inhibitory activity of new compounds towards HTLV-1 reverse transcriptase activity. 211
Ruolo della proteina virale vhs nel controllo della risposta innata cellulare mediata da PKR durante l’infezione da HSV-1. 204
HSV-1-induced activation of NF-κB protects U937 monocytic cells against both virus replication and apoptosis 203
Il fattore di trascrizione nucleare kappa b gioca un ruolo nell’immunità innata nei confronti dell’ infezione da HSV-1 in cellule monocitiche U937. 198
L’aumento della resa virale e dell’apoptosi in cellule monocitiche infettate da HSV-1 a seguito di inibizione di NF-kB non dipende dalla regolazione trascrizionale di TNF-α o IFN 198
Multilocus sequence typing reveals a new cluster of closely related Candida tropicalis genotypes in Italian patients with neurological disorders 197
Antioxidant Activity of a Sicilian Almond Skin Extract Using In Vitro and In Vivo Models 193
Activation of NF-KB in the very-early phase of HSV-1 infection: role of glycoprotein D/HveA interaction 190
Role of NF-kappa B transcription factor in innate response to HSV-1 infection of monocytic U937 cells 189
Anti-herpes simplex virus 1 and immunomodulatory activities of a poly-g- glutamic acid from Bacillus horneckiae strain APA of shallow vent origin 188
Coinvolgimento del recettore HVEM nell'attivazione di NF-kB da parte della glicoproteina D di HSV-1 186
NF-ΚB-dependent production of ROS and restriction of HSV-1 infection in U937 monocytic cells 183
Engagement of HSV-1 gD with HVEM cellular receptor induces NF-kB activation. 181
Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD 181
Inhibition of NF-kappaB activation enhances HSV-1 replication in U937 cells 180
La risposta innata nelle infezioni virali: ruolo del fattore nucleare kappa B. 179
Genetic diversity of Candida albicans isolates recovered from hospital environments and patients with severe acquired brain injuries 179
Apoptosi e Virus. 178
Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview 177
STUDI SUL RUOLO DI NF-KAPPA B E DELL’APOPTOSI NELL’ INFEZIONE DI CELLULE U937 DA PARTE DI HSV-1. 176
Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s disease. 176
Bcl-2 overexpression overcomes the incapability of monocytoid cells to sustain a fully-productive infection by HSV-2. 175
Forced expression of HveA renders cells sensitive to NF-kB activation by UV-inactivated HSV-1 or HSV-1 glycoprotein D. 175
Caspase-8 is required for HSV-1-induced apoptosis and promotes effective viral particle release via autophagy inhibition 174
Knockdown of Bcl-2 by siRNA abolishes the permissiveness state of HeLa cells to HSV-2 infection. 173
Herpes simplex virus and cell apoptotic response 173
AZT treatment potentiates apoptosis induction by NF-kB inhibitors in HTLV-1 infected cells 173
Signaling activity by herpes simplex virus: molecular mechanisms and biotechnological implications 172
Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α 171
L'over-espressione del protooncogene bcl-2 rende le cellule monocitoidi U937 pienamente permissive all'infezione da HSV-2. 170
Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells 170
Appraisal of a simple and effective RT-qPCR assay for evaluating the reverse transcriptase activity in blood samples from HIV-1 patients 168
A novel, rapid assay for evaluating the inhibitory activity of new compounds towards HTLV-1 reverse transcriptase activity 167
Involvement of HVEM receptor in activation of nuclear factor KB by HSV-1 glycoprotein D. 167
A novel, PCR-based for evaluating the HIV-RT inhibitory activity of antiretroviral compounds 167
Il silenziamento del protooncogene Bcl-2 mediante siRNA rende le cellule HeLa non permissive all'infezione da HSV-2. 165
Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSVA gD. 165
Ruolo dell'interazione glicoproteina D/recettore HVEA nell'attivazione precoce di NF-kB da parte di HSV-1. 164
L’ ATTIVAZIONE DI NF-KAPPA B E’ ASSOCIATA ALLA PARZIALE RESTRIZIONE DELL’ INFEZIONE DA HSV-1 IN CELLULE U937. 164
HVEM-mediated activationof nuclear factor kB by HSV-1 glycoprotein D. 161
Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol 159
Key role of Bcl-2 expression for productive HSV-2 replication. 157
Development and evaluation of a simple and effective RT-qPCR inhibitory assay for detection of the efficacy of compounds towards HIV reverse transcriptase 156
Role of herpesvirus entry Receptor A in replication-indipendent NF-kB activation by HSV-1. 155
Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors 155
Expression of genes encoding innate antiviral response in human monocytic cells, transfected or not with a dominant negative NF-kappa-B, following HSV-1 infection . 152
Signaling cellulare ed infezione da virus herpes simplex. 150
A novel, cell-free PCR-based assay for evaluating the inhibitory activity of antiretroviral compounds against HIV reverse transcriptase. 150
Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells 150
Future perspectives on drug targeting in adult T cell leukemia-lymphoma 147
Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB 146
Role of Caspase-8 in HSV-1 induced cell death 145
Apoptosis induced by HSV-1 requires BH3-only protein Puma and p73. 141
Binding of herpes simplex virus 1 to HVEM receptor through envelope glycoprotein D ensures protection against apoptosis. 140
D(-)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independent 139
NF-kB-dependent Protection From Apoptosis by HSV-1 gD/HVEM Interaction. 138
Lysosomal membrane permeabilization is involved in apoptosis induced by HSV-1 in monocytic cells 135
Testing anti-HIV activity of antiretroviral agents in vitro using infection of CEM-GFP cells with an HIV-1 NL4-3 recombinant strain and flow cytometry. 135
Signaling Pathway Utilized by HSV-1 to Induce NF-kB Activation: Possible Role of Herpesvirus Entry Receptor A. 135
Signaling pathway utilized by HSV-1 to induce NF-kB activation: possible role of herpesvirus entry receptor A. 134
Inhibition of NF-kB activation sensitizes U937 cells to 3’-azido-3’-deoxythymidine (AZT) induced apoptosis 132
Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3 131
Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer system in photodynamic cancer therapy 129
Polyester Resin and Carbon Nanotubes Based Nanocomposite as New Generation Coating to Prevent Biofilm Formation 127
Antiviral innate response in HSV-1 infected monocytic cells 125
N,O-Nucleoside Analogues: Metabolic and Apoptotic Activity 121
Sherris Microbiologia Medica 119
Synthesis and biological evaluation of styrylheterocycles analogs of resveratrol as apoptosis-inducing agents 118
Inhibition of NF-kB activation sensitizes U937 cells to 3’-azido-3’-deoxythymidine (AZT) induced apoptosis 117
Synthesis and biological evaluation of a new class of glycoconjugated disulfides that exhibit potential anticancer properties 116
Truncated phosphonated C-1'-branched N,O-nucleosides: A new class of antiviral agents. 115
Modulazione dell’attivazione di nf-kb da parte di 3’-azido-3’ deossitimidina (AZT): possibili implicazioni terapeutiche 114
Synthesis and biological testing of thioalkane- and thioarene-spaced bis-beta-D-glucopyranosides 113
Role of the Bh3-only protein Puma and p73 in apoptosis induced by herpes simplex virus 1 113
Excited triplet state behaviour , singlet oxygen photogeneration and photodynamic cellular damage of porphyrin embedded in cationic cyclodextrin vescicles. 110
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 109
Involvement of NF-kB activation in tipping the balance in favor of survival or apoptosis in 3’-azido-3’-deoxythymidine (AZT) treated cells 107
Functional NF-kappa B signaling restricts both virus replication and apoptosis in monocytic cells infected by HSV-1 107
Ruolo dell'espressione di Bcl-2 sullo stato di permissivita' cellulare all'infezione da HSV-2 in vitro 104
Wilde type gD of HSV-1, but not a mutated form incapable of binding HveA receptor, activates NF-kB in monocytoid cells. 103
Evaluation of the capability of antiviral compounds to inhibit retroviral reverse transcriptase by means of a novel assay 100
Nanoparticles of Cationic Amphiphilic Cyclodextrins entangling anionic porphyrins: a promising non-covalent “carrier/sensitizer” system in photodynamic cancer therapy 98
Phosphonated Nucleoside Analogues as Antiviral Agents 98
Se-(2-aminoalkyl)selenocysteines as biochemical redox agents. A tool to contrast cell injury induced by aflatoxin B1 in HepG2 cells 97
Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents 96
Synthesis and biological evaluation of novel small non-peptidic HIV-1 PIs: the benzothiophene ring as an effective moiety. 95
Determinazione della efficacia di composti di inibire la Trascrittasi Inversa di HIV mediante un nuovo saggio basato sulla reazione di PCR 93
Installing tungsten Fischer carbene complexes into a calixarene framework 92
Vie di segnale a valle del recettore HveA utilizzate da HSV-1 per indurre l'attivazione di NF-kB. 91
Effect of efavirenz and nevirapine on HIV reverse transcriptase activity through a novel, PCR-based assay. 90
Mechanisms involved in D(-) lentiginosine-induced apoptosis 86
Mixed nanoaggregates of cationic and galactosylated amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer systems for targeted PDT. 83
Truncated Phosphonated C-1’-Branched N,O-Nucleosides: a new class of antiretroviral agents 82
Quantitative Evaluation of Very Low Levels of HIV-1 Reverse Transcriptase by a Novel Highly Sensitive RT-qPCR Assay 81
Determination of sensitivity of HIV reverse transcriptase to inhibitory compounds by a new, cell free, PCR-based assay 81
Totale 14.942
Categoria #
all - tutte 52.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022566 0 0 0 27 32 9 44 31 10 30 159 224
2022/20232.021 150 244 83 162 125 195 33 122 822 14 47 24
2023/2024523 46 69 27 36 56 123 13 50 9 36 3 55
2024/20252.209 33 54 60 142 73 77 22 476 570 131 230 341
2025/20267.358 383 434 734 487 618 1.489 911 876 885 311 127 103
2026/20271.053 105 219 309 420 0 0 0 0 0 0 0 0
Totale 15.959